inhibition by tolbutamide and tolazamide of myocardial sarcolemmal ca2+-atpase is a mechanism by which these two sulfonylureas may at least transiently raise resting sarcoplasmic ca2+ concentration .
C0040374
tolbutamide
C0038766
sulfonylureas